Ascendis Pharma A/S (ASND)

ASND trades at $204.05, 4.6% above the near-term max pain of $195 expiring Oct 17, 2025 (12 days). Price stability likely with balanced options positioning at this level. Max pain is falling across expirations ($170-$260), signaling increased put positioning or downside protection. Key magnetic zone at 185 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for ASND shows a downward trend from 260 to 170, indicating bearish sentiment or hedging activity. The 46% spread signals divergent expectations across timeframes. Most levels below 204.05 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.